http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Oncogenic RAS-Pathway Activation Drives Oncofetal Reprogramming and Creates Therapeutic Vulnerabilities in Juvenile Myelomonocytic Leukemia
Hartmann, M.DKFZ* ; Schönung, M.DKFZ* ; Rajak, J. ; Maurer, V.DKFZ* ; Hai, L.DKFZ* ; Bauer, K.DKFZ* ; Hakobyan, M.DKFZ* ; Staeble, S. ; Langstein, J. ; Jardine, L. ; Rölz, R. ; Bohler, S. ; Khabirova, E. ; Maag, A.-H. ; Vonficht, D.DKFZ* ; Lebrecht, D. ; Bernt, K. M. ; Tan, K. ; Chen, C. ; Alikarami, F. ; Boch, T. ; Flore, N. V.DKFZ* ; Lutsik, P.DKFZ* ; Milsom, M. D.DKFZ* ; Raffel, S. ; Buske, C. ; Haas, S.DKFZ* ; Haniffa, M. ; Mallm, J.-P.DKFZ* ; Behjati, S. ; Bonder, M.-J. ; Fröhling, S.DKFZ* ; Niemeyer, C. M. ; Hey, J.DKFZ* ; Flotho, C.DKFZ* ; Plass, C.DKFZ* ; Erlacher, M. ; Schlesner, M.DKFZ* ; Lipka, D.DKFZ*
2023
This record in other databases: 
Please use a persistent id in citations: doi:10.1101/2023.10.27.563754
Contributing Institute(s):
- Epigenomik (B370)
- Translationale Medizinische Onkologie (B340)
- KKE Neuroonkologie (B320)
- A010 Stammzellen und Krebs (A010)
- scOpen Lab (W192)
- A012 Experimentelle Hämatologie (A012)
- W610 Core Facility Omics IT (W610)
Research Program(s):
- 312 - Funktionelle und strukturelle Genomforschung (POF4-312) (POF4-312)
Appears in the scientific report
2023